Sign up for free insights newsletter
00

Hanmi Science

008930KO

Need professional-grade analysis? Visit stockanalysis.com

₩37,600.00
+2.45%
Live (15-min delayed)
Market Cap

$2.58T

P/E Ratio

43.42

Employees

475

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.890.27-0.381.030.19
Calmar-2.330.46-0.491.110.02
Sharpe-0.580.18-0.250.650.11
Omega0.861.111.001.181.07
Martin-3.411.14-1.341.890.05
Ulcer21.2812.4011.3919.2115.81

Hanmi Science (008930) Price Performance

Hanmi Science (008930) trades on KO in KRW. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at KRW37600.00, up 2.45% from the previous close.

Over the past year, 008930 has traded between a low of KRW25000.00 and a high of KRW51900.00. The stock has gained 29.9% over this period. It is currently 29.3% below its 52-week high.

Hanmi Science has a market capitalization of $2.58T, with a price-to-earnings ratio of 43.42.

About Hanmi Science

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.

Company Info

Exchange
KO
Currency
KRW

Financial Metrics

Revenue (TTM)
$1.34T
EBITDA
$62.06B
Profit Margin
5.59%
EPS (TTM)
N/A
Book Value
840928.99

Technical Indicators

52 Week High
₩55,500.00
52 Week Low
₩24,250.00
50 Day MA
₩40,633.00
200 Day MA
₩40,642.25
Beta
0.67

Valuation

Trailing P/E
43.42
Forward P/E
N/A
Price/Sales
1.92
Price/Book
2.78
Enterprise Value
$2.70T